Seattle Genetics Inc. (SGEN) Tops Q1 EPS by 1c

Seattle Genetics Inc. (NASDAQ: SGEN) reported Q1 EPS of ($0.11), $0.01 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $48.2 million versus the consensus estimate of $52.33 million.

For earnings history and earnings-related data on Seattle Genetics Inc. (SGEN) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Rivian reports record Q3 deliveries, beats estimates, shares rise
• LTC Properties (LTC) PT Raised to $52 at RBC Capital
• Cuprina to buy seven-clinic Singapore healthcare group for S$4M